Cytokine‐induced interleukin‐1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment

BACKGROUND: A combination of tissue engineering methods employing mesenchymal stem cells (MSCs) together with gene transfer takes advantage of innovative strategies and highlights a new approach for targeting osteoarthritis (OA) and other cartilage defects. Furthermore, the development of systems al...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabner, Simone, Ertl, Reinhard, Velde, Karsten, Renner, Matthias, Jenner, Florien, Egerbacher, Monika, Hlavaty, Juraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001542/
https://www.ncbi.nlm.nih.gov/pubmed/29608232
http://dx.doi.org/10.1002/jgm.3021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001542/
https://www.ncbi.nlm.nih.gov/pubmed/29608232
http://dx.doi.org/10.1002/jgm.3021

Ejemplares similares